Celecoxib and Etoricoxib may reduce risk of ischemic stroke in patients with rheumatoid arthritis: A nationwide retrospective cohort study
ConclusionThis population-based retrospective cohort study has shown that Celecoxib and Etoricoxib reduce the risk of ischemic stroke in patients with RA in a dose- and time-dependent manner.
Source: Frontiers in Neurology - Category: Neurology Source Type: research
More News: Arthritis | Brain | Celebrex | Databases & Libraries | Health Insurance | Insurance | Ischemic Stroke | Neurology | Rheumatoid Arthritis | Rheumatology | Stroke | Study | Taiwan Health